Opendata, web and dolomites

REpiReg SIGNED

RNAi-mediated Epigenetic Gene Regulation

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 REpiReg project word cloud

Explore the words cloud of the REpiReg project. It provides you a very rough idea of what is the project "REpiReg" about.

link    employ    expression    counter    perform    close    exogenously    rnai    nucleases    sirnas    endogenous    genome    chromatin    foundation    sequences    conservation    initiation    rna    hampered    experiments    regulatory    single    missing    chemical    conserved    acting    sequencing    engineered    silence    consists    gaps    epigenome    decade    discovered    modifications    synthetic    components    regulation    cutting    fragments    cell    mechanistic    epigenetics    trigger    difficult    epigenetic    organisms    critical    technologies    additional    embryonic    direct    sparked    controversy    suppressive    de    questions    yeast    eukaryotic    impedes    beginning    proteomics    dissection    stem    principles    constitutes    unanswered    genetic    mammalian    editing    mediated    trans    surprising    phenomenon    small    screens    homologous    heterochromatin    refers    systematic    mechanism    rnas    ago    combined    edge    cells    intriguing    gene    possibility    mutagenesis    fission    mouse    outstanding    builds    fundamental    fortunate    directed    novo    inherently    elucidate   

Project "REpiReg" data sheet

The following table provides information about the project.

Coordinator
FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH FONDATION 

Organization address
address: MAULBEERSTRASSE 66
city: BASEL
postcode: 4058
website: www.fmi.ch

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Switzerland [CH]
 Project website https://buehlerlab.org/awards-honors/
 Total cost 1˙998˙557 €
 EC max contribution 1˙998˙557 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2015-CoG
 Funding Scheme ERC-COG
 Starting year 2017
 Duration (year-month-day) from 2017-01-01   to  2021-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH FONDATION CH (BASEL) coordinator 1˙998˙557.00

Map

 Project objective

RNAi refers to the ability of small RNAs to silence expression of homologous sequences. A surprising link between epigenetics and RNAi was discovered more than a decade ago, and I was fortunate enough to be involved in this exciting field of research from the beginning. It is now well established that endogenous small RNAs have a direct impact on the genome in various organisms. Yet, the initiation of chromatin modifications in trans by exogenously introduced small RNAs has been inherently difficult to achieve in all eukaryotic cells. This has sparked controversy about the importance and conservation of RNAi-mediated epigenome regulation and hampered systematic mechanistic dissection of this phenomenon. Using fission yeast, we have discovered a counter-acting mechanism that impedes small RNA-directed formation of heterochromatin and constitutes the foundation of this proposal. Our goal is to close several knowledge gaps and test the intriguing possibility that the suppressive mechanism we discovered is conserved in mammalian cells. We will employ yeast and embryonic stem cells and use cutting-edge technologies (i.e., chemical mutagenesis combined with whole-genome sequencing, genome editing with engineered nucleases, and single-cell RNA sequencing) to address fundamental, as yet unanswered questions. My proposal consists of four major aims. In aim 1, I propose to use proteomics approaches and to perform yeast genetic screens to define additional pathway components and regulatory factors. Aim 2 builds on our ability to finally trigger de novo formation of heterochromatin by synthetic siRNAs acting in trans, addressing many of the outstanding mechanistic questions that could not be addressed in the past. In Aims 3 and 4, experiments conducted in yeast and mouse cells will elucidate missing fragments critical to our understanding of the conserved principles behind RNAi-mediated epigenetic gene regulation.

 Publications

year authors and title journal last update
List of publications.
2016 Yukiko Shimada, Fabio Mohn, Marc Bühler
The RNA-induced transcriptional silencing complex targets chromatin exclusively via interacting with nascent transcripts
published pages: 2571-2580, ISSN: 0890-9369, DOI: 10.1101/gad.292599.116
Genes & Development 30/23 2019-06-18
2017 Valentin Flury, Paula Raluca Georgescu, Vytautas Iesmantavicius, Yukiko Shimada, Tahsin Kuzdere, Sigurd Braun, Marc B?hler
The Histone Acetyltransferase Mst2 Protects Active Chromatin from Epigenetic Silencing by Acetylating the Ubiquitin Ligase Brl1
published pages: , ISSN: 1097-2765, DOI: 10.1016/j.molcel.2017.05.026
Molecular Cell 2019-06-18
2019 Lea Duempelmann, Fabio Mohn, Yukiko Shimada, Daniele Oberti, Aude Andriollo, Silke Lochs, Marc Bühler
Inheritance of a Phenotypically Neutral Epimutation Evokes Gene Silencing in Later Generations
published pages: 534-541.e4, ISSN: 1097-2765, DOI: 10.1016/j.molcel.2019.02.009
Molecular Cell 74/3 2019-08-30

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "REPIREG" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "REPIREG" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

NEUTRAMENTH (2018)

A redox-neutral process for the cost-efficient and environmentally friendly production of Menthol

Read More  

HyperBio (2019)

Vis-NIR Hyperspectral imaging for biomaterial quality control

Read More  

CHIPTRANSFORM (2018)

On-chip optical communication with transformation optics

Read More